{"id":"https://openalex.org/W7223099835","doi":"https://doi.org/10.1016/j.htct.2026.107890","title":"MANUTEN\u00c7\u00c3O INTENSIFICADA VERSUS LENALIDOMIDA ISOLADA NO MIELOMA M\u00daLTIPLO ELEG\u00cdVEL AO TRANSPLANTE AUT\u00d3LOGO: UMA REVIS\u00c3O SISTEM\u00c1TICA","display_name":"MANUTEN\u00c7\u00c3O INTENSIFICADA VERSUS LENALIDOMIDA ISOLADA NO MIELOMA M\u00daLTIPLO ELEG\u00cdVEL AO TRANSPLANTE AUT\u00d3LOGO: UMA REVIS\u00c3O SISTEM\u00c1TICA","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223099835","doi":"https://doi.org/10.1016/j.htct.2026.107890"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.107890","doi":"https://doi.org/10.1016/j.htct.2026.107890","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107890","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2026.107890","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159219431","display_name":"Julia Azevedo Parreira MARTINS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100867","display_name":"Centro Universit\u00e1rio do Par\u00e1","ror":"https://ror.org/012835d77","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210100867"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Julia Azevedo Parreira MARTINS","raw_affiliation_strings":["Centro Universit\u00e1rio do Estado do Par\u00e1 (CESUPA), Bel\u00e9m, PA, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Universit\u00e1rio do Estado do Par\u00e1 (CESUPA), Bel\u00e9m, PA, Brasil","institution_ids":["https://openalex.org/I4210100867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159173606","display_name":"Nicole Klautau TOFFOLI","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59606676","display_name":"Universidade Federal do Par\u00e1","ror":"https://ror.org/03q9sr818","country_code":"BR","type":"education","lineage":["https://openalex.org/I59606676"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Nicole Klautau TOFFOLI","raw_affiliation_strings":["Universidade Federal do Par\u00e1 (UFPA), Bel\u00e9m, PA, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Par\u00e1 (UFPA), Bel\u00e9m, PA, Brasil","institution_ids":["https://openalex.org/I59606676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159207289","display_name":"Sophia Gouveia DAMASCENO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59606676","display_name":"Universidade Federal do Par\u00e1","ror":"https://ror.org/03q9sr818","country_code":"BR","type":"education","lineage":["https://openalex.org/I59606676"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Sophia Gouveia DAMASCENO","raw_affiliation_strings":["Universidade Federal do Par\u00e1 (UFPA), Bel\u00e9m, PA, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Par\u00e1 (UFPA), Bel\u00e9m, PA, Brasil","institution_ids":["https://openalex.org/I59606676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159172575","display_name":"Jo\u00e3o Gabriel de Oliveira S\u00c1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100867","display_name":"Centro Universit\u00e1rio do Par\u00e1","ror":"https://ror.org/012835d77","country_code":"BR","type":"education","lineage":["https://openalex.org/I4210100867"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Gabriel de Oliveira S\u00c1","raw_affiliation_strings":["Centro Universit\u00e1rio do Estado do Par\u00e1 (CESUPA), Bel\u00e9m, PA, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Universit\u00e1rio do Estado do Par\u00e1 (CESUPA), Bel\u00e9m, PA, Brasil","institution_ids":["https://openalex.org/I4210100867"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021417811","display_name":"Nonato M\u00e1rcio Cust\u00f3dio Maia S\u00e1","orcid":"https://orcid.org/0000-0001-8673-6956","observed_orcids":["https://orcid.org/0000-0001-8673-6956"]},"institutions":[{"id":"https://openalex.org/I211891151","display_name":"Universidade do Estado do Par\u00e1","ror":"https://ror.org/042r36z33","country_code":"BR","type":"education","lineage":["https://openalex.org/I211891151"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Nonato M\u00e1rcio Cust\u00f3dio Maia S\u00e1","raw_affiliation_strings":["Universidade do Estado do Par\u00e1 (UEPA), Bel\u00e9m, PA, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade do Estado do Par\u00e1 (UEPA), Bel\u00e9m, PA, Brasil","institution_ids":["https://openalex.org/I211891151"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.78098654,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"107890","last_page":"107890"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9679999947547913},{"id":"https://openalex.org/keywords/krd","display_name":"KRd","score":0.5509999990463257},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.8379999995231628},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.8209999799728394},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9850000143051147},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8500000238418579},{"id":"https://openalex.org/keywords/atlas-trial","display_name":"ATLAS trial","score":0.6359999775886536},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.6269999742507935},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.39399999380111694},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9660000205039978},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.38190001249313354},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.3197999894618988},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.26170000433921814},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.249099999666214},{"id":"https://openalex.org/C2780387249","wikidata":"https://www.wikidata.org/wiki/Q973234","display_name":"Radiosurgery","level":3,"score":0.24690000712871552},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.2345999926328659},{"id":"https://openalex.org/C2778964538","wikidata":"https://www.wikidata.org/wiki/Q2090167","display_name":"Plasmacytoma","level":3,"score":0.19930000603199005},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.18170000612735748}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.107890","doi":"https://doi.org/10.1016/j.htct.2026.107890","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107890","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:7ac14904790340aea7efcc12d109d0b6","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/7ac14904790340aea7efcc12d109d0b6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 107890- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.107890","doi":"https://doi.org/10.1016/j.htct.2026.107890","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107890","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979470596","https://openalex.org/W2062388515","https://openalex.org/W7120345097","https://openalex.org/W7024659153","https://openalex.org/W2792453604","https://openalex.org/W2757419262","https://openalex.org/W4415150426","https://openalex.org/W2790596875","https://openalex.org/W2944933957","https://openalex.org/W7135035068"],"abstract_inverted_index":{"Introdu\u00e7\u00e3o":[0],"O":[1],"mieloma":[2,114,419],"m\u00faltiplo":[3,115,420],"\u00e9":[4,30],"uma":[5],"neoplasia":[6],"hematol\u00f3gica":[7],"caracterizada":[8],"pela":[9,211,440],"prolifera\u00e7\u00e3o":[10],"clonal":[11],"de":[12,26,40,61,72,84,99,109,125,135,140,207,243,258,264,279,291,303,307,319,344,406,414,450],"plasm\u00f3citos":[13],"na":[14,24,332],"medula":[15],"\u00f3ssea.":[16],"A":[17,152,195],"lenalidomida":[18,45,81,103,234,250,273,300,367,438],"isolada":[19,104,251],"consolidou-se":[20],"como":[21,82],"tratamento":[22,34],"padr\u00e3o":[23],"terapia":[25,83],"manuten\u00e7\u00e3o,":[27,85],"a":[28,44,69,77,89,218,230,377,411],"qual":[29],"administrada":[31],"ap\u00f3s":[32],"o":[33,59,63,205,241,277,328,339,355,459],"inicial.":[35],"Nesse":[36],"contexto,":[37],"novas":[38],"estrat\u00e9gias":[39,98,351,405],"manuten\u00e7\u00e3o":[41,100,231,380,407],"combinada":[42],"associando":[43],"ao":[46,53,118,422],"carfilzomibe,":[47,233,353],"com":[48,58,113,232,255,286,313,350,363,384,418,426],"ou":[49,52,144,245,281,309],"sem":[50],"dexametasona,":[51],"daratumumabe,":[54],"v\u00eam":[55],"sendo":[56],"investigadas":[57],"objetivo":[60],"intensificar":[62],"controle":[64],"da":[65,80,91,148,346,379,443,448,461],"doen\u00e7a":[66,149,347,444],"e":[67,122,142,161,182,193,204,226,235,390,393,399],"prolongar":[68],"sobrevida":[70,107,138,256,412,454],"livre":[71,108,139,257,413],"progress\u00e3o.":[73],"No":[74,228,268,295],"cen\u00e1rio":[75],"brasileiro,":[76],"recente":[78],"incorpora\u00e7\u00e3o":[79],"no":[86,201,305,388,391,396],"SUS,":[87],"refor\u00e7a":[88],"relev\u00e2ncia":[90],"discuss\u00e3o":[92],"sobre":[93],"estas":[94],"estrat\u00e9gias.":[95],"Objetivos":[96],"Comparar":[97],"intensificada":[101,408],"versus":[102,266,293,321,369],"quanto":[105,381],"\u00e0":[106,249,272,299,336,366,382,437],"progress\u00e3o":[110,141,244,259,280,308,415],"em":[111,239,247,261,275,288,316,416,432,453],"pacientes":[112,417],"rec\u00e9m-diagnosticado":[116],"eleg\u00edveis":[117,421],"transplante":[119,423],"aut\u00f3logo.":[120,424],"Material":[121],"m\u00e9todos":[123],"Trata-se":[124],"revis\u00e3o":[126],"sistem\u00e1tica":[127],"conduzida":[128],"conforme":[129],"as":[130],"recomenda\u00e7\u00f5es":[131],"PRISMA.":[132],"Os":[133,401],"desfechos":[134],"interesse":[136],"foram":[137,222],"negatividade":[143,147,345],"convers\u00e3o":[145,359],"para":[146,360],"residual":[150,348,445],"mensur\u00e1vel.":[151,446],"busca":[153],"foi":[154,199,209],"realizada":[155,200],"nas":[156],"bases":[157],"PubMed,":[158],"Cochrane":[159,213],"Library":[160],"SciELO,":[162],"complementada":[163],"pelo":[164],"Google":[165],"Acad\u00eamico,":[166],"utilizando":[167],"os":[168,374,456],"descritores":[169],"\u201cMultiple":[170],"Myeloma\u201d,":[171],"\u201cMaintenance":[172],"Chemotherapy\u201d,":[173],"\u201cHematopoietic":[174],"Stem":[175],"Cell":[176],"Transplantation\u201d,":[177],"\u201cautologous":[178],"stem":[179],"cell":[180],"transplant\u201d":[181],"\u201crandomized":[183],"controlled":[184],"trial\",":[185],"incluindo":[186],"ensaios":[187],"cl\u00ednicos":[188],"randomizados":[189],"publicados":[190],"entre":[191],"2020":[192],"2026.":[194],"sele\u00e7\u00e3o":[196],"dos":[197],"estudos":[198,221,375,402],"software":[202],"Rayyan,":[203],"risco":[206,242,278,306],"vi\u00e9s":[208],"avaliado":[210],"ferramenta":[212],"RoB":[214],"2.":[215],"Resultados":[216],"Ap\u00f3s":[217],"triagem,":[219],"tr\u00eas":[220],"inclu\u00eddos:":[223],"ATLAS,":[224,229],"FORTE":[225,340,392],"AURIGA.":[227,397],"dexametasona":[236],"(KRd)":[237],"reduziu":[238,274],"54%":[240],"morte":[246,282,310],"compara\u00e7\u00e3o":[248],"(HR":[252,283,311],"0,46;":[253],"p=0,0002),":[254],"(SLP)":[260],"4":[262],"anos":[263,290],"67,5%":[265],"38,0%.":[267],"FORTE,":[269],"carfilzomibe":[270,427],"associado":[271,298,365,436],"36%":[276],"0,64;":[284],"p=0,023),":[285],"SLP":[287,314],"3":[289],"75%":[292],"65%.":[294],"AURIGA,":[296],"daratumumabe":[297,364,435],"apresentou":[301],"redu\u00e7\u00e3o":[302],"47%":[304],"0,53),":[312],"estimada":[315],"30":[317],"meses":[318],"82,7%":[320],"66,4%;":[322],"contudo,":[323],"esse":[324],"resultado":[325],"n\u00e3o":[326],"atingiu":[327],"limite":[329],"estat\u00edstico":[330],"pr\u00e9-especificado":[331],"an\u00e1lise":[333],"interina.":[334],"Quanto":[335],"resposta":[337],"terap\u00eautica,":[338],"demonstrou":[341],"maior":[342,358,441],"frequ\u00eancia":[343],"mensur\u00e1vel":[349],"contendo":[352],"enquanto":[354,434],"AURIGA":[356],"evidenciou":[357],"DRM":[361],"negativa":[362],"(50,5%":[368],"18,8%;":[370],"p<0,0001).":[371],"Em":[372],"conjunto,":[373],"favorecem":[376],"intensifica\u00e7\u00e3o":[378,462],"SLP,":[383,433],"benef\u00edcio":[385,429,451],"estatisticamente":[386],"significativo":[387],"ATLAS":[389],"sinal":[394],"favor\u00e1vel":[395],"Discuss\u00e3o":[398],"conclus\u00e3o":[400],"sugerem":[403],"que":[404],"podem":[409],"melhorar":[410],"Regimes":[425],"apresentaram":[428],"mais":[430],"consistente":[431],"destacou-se":[439],"negativa\u00e7\u00e3o":[442],"Apesar":[447],"aus\u00eancia":[449],"definitivo":[452],"global,":[455],"achados":[457],"refor\u00e7am":[458],"potencial":[460],"terap\u00eautica.":[463]},"counts_by_year":[],"updated_date":"2026-10-26T11:51:55.731654","created_date":"2026-10-22T00:00:00"}